PGT-121

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NamePGT-121
Drug Alias NamePGT-121
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTransmembrane glycoprotein gp41 modulatorsHIV envelope protein gp120 modulators
TargetsTransmembrane glycoprotein gp41HIV envelope protein gp120
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsSexually Transmitted Diseases, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInternational Aids Vaccine InitiativeTheraclone Sciences IncThe Scripps Research Institute Inc +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesOrlando Immunology CenterBeth Israel Deaconess Medical CenterHarvard School Of Public Health +[6] 
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsSexually Transmitted Diseases, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A